The Journal of Community and Supportive OncologyImmunotherapies shape the treatment landscape for hematologic malignanciesAugust 15, 2018Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationImmunotherapyFollicular LymphomaB Cell Lymphoma
Hematology TimesInsurance status linked to survival in FL patientsAugust 11, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Oncology PracticeInsurance is a matter of life or death for lymphoma patientsAugust 6, 2018Practice ManagementLymphoma & Plasma Cell DisordersIndolent LymphomaBusiness of MedicineFollicular Lymphoma
Hematology TimesTreatment improves PFS in early stage FLAugust 2, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology NewsRituximab reduces risk of follicular lymphoma transformationJuly 25, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular LymphomaB Cell Lymphoma
Hematology TimesHealth Canada expands approval of obinutuzumabJuly 10, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesTransplant strategy not viable for aggressive B-NHLJuly 6, 2018Lymphoma & Plasma Cell DisordersTransplantationNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology TimesCHMP recommends CAR T for DLBCL, PMBCLJuly 2, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology TimesDoc reports favorable results from trial on holdJune 29, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology TimesInhibitor exhibits activity in B- and T-cell NHLsJune 21, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology NewsDLBCL survival improved with novel antibody-drug conjugateJune 17, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology Times‘Excellent’ survival with HCT despite early treatment failure in FLJune 16, 2018Lymphoma & Plasma Cell DisordersTransplantationAggressive LymphomasFollicular Lymphoma
Hematology TimesChemo-free combo provides potential first-line option for FLJune 12, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesPolatuzumab plus BR improves efficacy in DLBCLJune 8, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology NewsChemo-free regimen appears viable in previously untreated FLJune 7, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
